
### [MONDO:0005571](http://purl.obolibrary.org/obo/MONDO_0005571)
**Label:** polycythemia

**Subclasses:** [MONDO:0016599](http://purl.obolibrary.org/obo/MONDO_0016599) (autosomal dominant secondary polycythemia), [MONDO:0016540](http://purl.obolibrary.org/obo/MONDO_0016540) (congenital secondary polycythemia), [MONDO:0016541](http://purl.obolibrary.org/obo/MONDO_0016541) (acquired secondary polycythemia), [MONDO:0020115](http://purl.obolibrary.org/obo/MONDO_0020115) (secondary polycythemia), 

**Corr. equiv. classes:** [Orphanet:247511](http://www.orpha.net/ORDO/Orphanet_247511), [Orphanet:238547](http://www.orpha.net/ORDO/Orphanet_238547), [Orphanet:238536](http://www.orpha.net/ORDO/Orphanet_238536), [OMIM:611783](http://purl.obolibrary.org/obo/OMIM_611783), [OMIM:609820](http://purl.obolibrary.org/obo/OMIM_609820), [Orphanet:98428](http://www.orpha.net/ORDO/Orphanet_98428), 

**Class expressions from DL-Learner:**

- [HP:0001900](http://purl.obolibrary.org/obo/HP_0001900) (Increased hemoglobin) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and [HP:0001900](http://purl.obolibrary.org/obo/HP_0001900) (Increased hemoglobin) 66.67%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) 66.67%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0100570](http://purl.obolibrary.org/obo/HP_0100570) (Carcinoid tumor))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0100007](http://purl.obolibrary.org/obo/HP_0100007) (Neoplasm of the peripheral nervous system))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0031440](http://purl.obolibrary.org/obo/HP_0031440) (Abnormal tricuspid valve morphology))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0031273](http://purl.obolibrary.org/obo/HP_0031273) (Shock))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0030956](http://purl.obolibrary.org/obo/HP_0030956) (Abnormality of cardiovascular system electrophysiology))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0030872](http://purl.obolibrary.org/obo/HP_0030872) (Abnormal cardiac ventricular function))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0030405](http://purl.obolibrary.org/obo/HP_0030405) (Pancreatic endocrine tumor))) 66.67%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and (not ([HP:0030404](http://purl.obolibrary.org/obo/HP_0030404) (Glucagonoma))) 66.67%


